Nitrocamptothecin in Treating Patients With Advanced or Recurrent Colorectal Cancer

NCT00005877 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: rubitecan

Sponsor

Astex Pharmaceuticals, Inc.